Valuation: RAMM Pharma Corp.

Market Cap 11.94L 9L 7L 7L 6L 8.3Cr 12.1L 82.11L 32.02L 4.17Cr 32.56L 31.85L 14Cr P/E 2024
-0.07x
P/E 2025 -0.2x
Enterprise Value 5L 3L 3L 3L 3L 3.27Cr 5L 32.35L 12.62L 1.64Cr 12.83L 12.55L 5.43Cr EV / Sales 2024
0.13x
EV / Sales 2025 0.32x
Free-Float
68.57%
Yield 2024 *
-
Yield 2025 -
3 months-33.33%
6 months-50.00%
Current year-83.33%
1 week 0.01
Extreme 0.01
0.01
1 month 0.01
Extreme 0.01
0.01
Current year 0
Extreme 0.005
0.05
1 year 0
Extreme 0.005
0.25
3 years 0
Extreme 0
0.25
5 years 0
Extreme 0
0.75
10 years 0
Extreme 0
1.19
Manager TitleAgeSince
Chief Executive Officer - 01/10/2019
Director of Finance/CFO - 09/12/2022
Director TitleAgeSince
Director/Board Member - 01/10/2019
Director/Board Member 82 01/10/2019
Director/Board Member 66 01/10/2019
Date Insider Type Main position Quantity % Market Cap.
02/06/25 Sell

Chief Executive Officer

46,67,000 3.9091%
21/03/25 Buy

Chief Executive Officer

2,00,000 0.1675%
21/03/25 Buy

Chief Executive Officer

1,00,000 0.0838%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%0.00%-77.78% 9L
+0.88%+6.38%+76.40%+126.75% 1,11900Cr
+1.07%+3.80%+50.73%+62.78% 65TCr
+1.20%+6.21%+25.81%+78.74% 47TCr
+1.02%+5.77%+43.63%+48.43% 37TCr
+0.85%+4.07%+24.97%+40.58% 30TCr
+1.26%+6.81%+2.27%+14.41% 26TCr
+1.88%+5.81%+49.57%+70.53% 24TCr
+1.59%+2.09%-17.33%-52.62% 21TCr
+1.87%+5.61%+27.32%+91.38% 18TCr
Average +1.16%+4.48%+28.34%+40.32% 38TCr
Weighted average by Cap. +1.14%+5.09%+44.26%+72.65%

Financials

2024 2025
Net sales 43.42L 31.53L 27.01L 25.27L 23.14L 30Cr 43.99L 2.99Cr 1.16Cr 15Cr 1.18Cr 1.16Cr 50Cr 33.61L 24.41L 20.91L 19.56L 17.91L 23Cr 34.05L 2.31Cr 90.13L 12Cr 91.65L 89.65L 39Cr
Net income -1.65Cr -1.2Cr -1.03Cr -96.06L -87.93L -114.67Cr -1.67Cr -11Cr -4.43Cr -58Cr -4.5Cr -4.4Cr -190.53Cr -89.1L -64.71L -55.43L -51.87L -47.48L -62Cr -90.28L -6.13Cr -2.39Cr -31Cr -2.43Cr -2.38Cr -102.87Cr
Net Debt -6L -5L -4L -4L -3L -4.35Cr -6L -43.03L -16.78L -2.18Cr -17.06L -16.69L -7.22Cr -7L -5L -5L -4L -4L -5.03Cr -7L -49.76L -19.4L -2.53Cr -19.73L -19.3L -8.35Cr
Logo RAMM Pharma Corp.
RAMM Pharma Corp. is a Canada-based company that is primarily engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. It has multiple approved and registered products that have been authorized for sale, as well as other products in various stages of development. The Company also operates GMP certified cannabis formulation facilities in Uruguay and Poland to ensure their products are compliant with the standard and address international markets. The Company owns and operates a medical services business in Uruguay and a cosmetic and nutraceutical business in the European Union. The Company's brands include Medic Plast, Nettalife, Canapar, and Marishanti. Its subsidiaries include Medic Plast S.A., Yurelan S.A., RAMM Pharma Holdings Corp., Canapar Corp, and Hempoland S.p.a Z.o.o.
Employees
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. RAMM Stock